Skip to main content
Fig. 1 | BMC Endocrine Disorders

Fig. 1

From: Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma

Fig. 1

a Steroid pathway diagram indicating the observed changes in steroid metabolite concentrations in ACC patients compared to CPA patients. DHEAS: dehydroepiandrosterone sulfate. b Comparison of indicated serum concentrations of steroids and urinary 17-ketosteroid excretion between ACC and CPA. DHEAS: dehydroepiandrosterone sulfate. ACC: adrenocortical carcinomas, CPA: cortisol-producing adenomas. P < 0.05 was defined as significant. *: < 0.05, **: < 0.01, *** < 0.001, NS: nonsignificant

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us